Total Payments
$769.25
2024 Payments
$39.89
Companies
9
Transactions
53
Medicare Patients
400
Medicare Billing
$79,112
Payment Breakdown by Category
Food & Beverage$719.25 (93.5%)
Education$50.00 (6.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $719.25 | 52 | 93.5% |
| Education | $50.00 | 1 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $395.56 | 29 | $0 (2023) |
| Lilly USA, LLC | $126.85 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $64.26 | 2 | $0 (2022) |
| PFIZER INC. | $60.44 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $47.57 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $23.55 | 2 | $0 (2017) |
| ABBVIE INC. | $22.65 | 1 | $0 (2024) |
| Allergan Inc. | $14.67 | 1 | $0 (2017) |
| Esperion Therapeutics, Inc. | $13.70 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.89 | 2 | ABBVIE INC. ($22.65) |
| 2023 | $87.17 | 5 | Lilly USA, LLC ($53.13) |
| 2022 | $250.86 | 16 | Novo Nordisk Inc ($130.12) |
| 2021 | $90.03 | 6 | Novo Nordisk Inc ($90.03) |
| 2020 | $68.53 | 5 | Novo Nordisk Inc ($54.83) |
| 2019 | $86.11 | 7 | Novo Nordisk Inc ($48.81) |
| 2018 | $72.45 | 6 | PFIZER INC. ($25.57) |
| 2017 | $74.21 | 6 | SANOFI-AVENTIS U.S. LLC ($23.55) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 05/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Diabetes | ||||||
| 01/31/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 01/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 12/15/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $50.00 | General |
| 12/06/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Diabetes | ||||||
| 11/29/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Urology | ||||||
| 11/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 11/01/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Diabetes | ||||||
| 09/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 08/23/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes | ||||||
| 07/26/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 06/21/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 06/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Diabetes | ||||||
| 06/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
| 04/20/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Diabetes | ||||||
| 04/06/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 03/01/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 01/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 11/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 08/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 52 | 173 | $28,515 | $12,870 |
| 2022 | 3 | 108 | 302 | $43,617 | $21,135 |
| 2021 | 3 | 107 | 317 | $45,008 | $24,049 |
| 2020 | 3 | 133 | 357 | $46,015 | $21,057 |
Total Patients
400
Total Services
1,149
Medicare Billing
$79,112
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 173 | $28,515 | $12,870 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 253 | $40,480 | $19,930 | 49.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,625 | $699.03 | 43.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 24 | 24 | $1,512 | $505.39 | 33.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 271 | $42,547 | $23,205 | 54.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 23 | 23 | $1,173 | $472.19 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,288 | $372.37 | 28.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 293 | $43,071 | $19,917 | 46.2% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 32 | 32 | $1,472 | $626.56 | 42.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 32 | 32 | $1,472 | $514.24 | 34.9% |
About Dr. William Polley, MD
Dr. William Polley, MD is a Internal Medicine healthcare provider based in Fairlawn, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588683650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Polley, MD has received a total of $769.25 in payments from pharmaceutical and medical device companies, with $39.89 received in 2024. These payments were reported across 53 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($719.25).
As a Medicare-enrolled provider, Polley has provided services to 400 Medicare beneficiaries, totaling 1,149 services with total Medicare billing of $79,112. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fairlawn, OH
- Active Since 07/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588683650
Products in Payments
- Ozempic (Drug) $266.00
- MOUNJARO (Drug) $83.03
- Rybelsus (Drug) $79.70
- CHANTIX (Drug) $50.02
- TRULICITY (Drug) $43.82
- XARELTO (Drug) $34.72
- Victoza (Drug) $25.95
- Tresiba (Drug) $23.91
- QULIPTA (Drug) $22.65
- NAMZARIC (Drug) $14.67
- Myrbetriq (Drug) $14.26
- NEXLETOL (Drug) $13.70
- INVOKANA (Drug) $12.85
- TOUJEO (Drug) $11.92
- PRALUENT (Drug) $11.63
- ELIQUIS (Drug) $10.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fairlawn
Michael Gedeon, Md, MD
Internal Medicine — Payments: $14,715
Internal Medicine $14,715
Jeffrey Eckman, Md, MD
Internal Medicine — Payments: $13,887
Internal Medicine $13,887
Mr. Richard Card, D.o, D.O
Internal Medicine — Payments: $6,819
Internal Medicine $6,819
Rebekka Hom
Internal Medicine — Payments: $1,097
Internal Medicine $1,097
Rashmi Srivastava, M.d, M.D
Internal Medicine — Payments: $598.27
Internal Medicine $598.27
Samantha Marie Almendras, Md, MD
Internal Medicine — Payments: $478.32
Internal Medicine $478.32